Marex Group plc Invests $580,000 in Agilent Technologies, Inc. $A

Marex Group plc acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,914 shares of the medical research company’s stock, valued at approximately $580,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Agilent Technologies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after purchasing an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares during the last quarter. Geode Capital Management LLC lifted its position in Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after buying an additional 115,183 shares during the period. Generation Investment Management LLP boosted its stake in Agilent Technologies by 15.9% in the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after buying an additional 792,304 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after buying an additional 604,124 shares during the period.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $139.56 on Monday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $39.57 billion, a P/E ratio of 30.54, a PEG ratio of 4.05 and a beta of 1.27. The firm has a fifty day moving average of $145.59 and a 200-day moving average of $129.27. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the prior year, the firm earned $1.46 EPS. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 21.66%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on A shares. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. UBS Group upped their price objective on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Finally, Bank of America increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $161.77.

Insider Buying and Selling

In other news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. This trade represents a 27.19% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.